Protein Summary
In vitro can degrade the fibrinogen alpha chain of as well as pro-urokinase-type plasminogen activator.
- ENST00000280606
- ENSP00000280606
- ENSG00000151006
- POL3S
- UNQ308
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
cell type or tissue | 0.82 | ||
small molecule perturbation | 0.61 | ||
protein domain | 0.58 | ||
tissue sample | 0.51 | ||
cell line | 0.48 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 4.97 (req: < 5)
Gene RIFs: 1 (req: <= 3)
Antibodies: 29 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 4.97 (req: >= 5)
Gene RIFs: 1 (req: > 3)
Antibodies: 29 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Term: 1
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0